Last reviewed · How we verify

Placebo of DA-5515

Dong-A Pharmaceutical · FDA-approved active Small molecule

Placebo of DA-5515 is a Small molecule drug developed by Dong-A Pharmaceutical. It is currently FDA-approved for Clinical trial control arm (not a therapeutic indication). Also known as: Placebo capsule.

A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.

A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Clinical trial control arm (not a therapeutic indication).

At a glance

Generic namePlacebo of DA-5515
Also known asPlacebo capsule
SponsorDong-A Pharmaceutical
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

Placebo is an inert substance used as a control in clinical trials to establish baseline efficacy and safety profiles of active drugs. Any observed effects are attributable to the placebo effect—psychological and physiological responses to the expectation of treatment rather than direct drug action. Placebos are essential for blinded study designs to isolate true drug efficacy from patient expectation and natural disease progression.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo of DA-5515

What is Placebo of DA-5515?

Placebo of DA-5515 is a Small molecule drug developed by Dong-A Pharmaceutical, indicated for Clinical trial control arm (not a therapeutic indication).

How does Placebo of DA-5515 work?

A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.

What is Placebo of DA-5515 used for?

Placebo of DA-5515 is indicated for Clinical trial control arm (not a therapeutic indication).

Who makes Placebo of DA-5515?

Placebo of DA-5515 is developed and marketed by Dong-A Pharmaceutical (see full Dong-A Pharmaceutical pipeline at /company/dong-a-pharmaceutical).

Is Placebo of DA-5515 also known as anything else?

Placebo of DA-5515 is also known as Placebo capsule.

What development phase is Placebo of DA-5515 in?

Placebo of DA-5515 is FDA-approved (marketed).

Related